This award was established in 1996 to recognize outstanding achievements in clinical cancer research. It is named for the late Dr. Joseph H. Burchenal, honorary member and past president of the AACR, and a major figure in clinical cancer research and chemotherapy.
The winner of the AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research will give an award lecture during the AACR Annual Meeting 2020, in San Diego, California, USA, receive an honorarium of $10,000, and will be given support for the winner and a guest to attend the Annual Meeting.
Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.
The award will be presented to an individual investigator.
Institutions or organizations are not eligible for the award.
Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Self-nominations are prohibited.
Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically to https://myaacr.aacr.org. Paper nominations will not be accepted.
See the Program Guidelines and Nomination Instructions for complete details.
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the award winner will be made on the basis of the candidate's achievements in clinical cancer research. No regard will be given to age, race, gender, nationality, geographic location or religious or political views.